Nuveen Asset Management LLC Takes Position in Grail, Inc. (NASDAQ:GRAL)

Nuveen Asset Management LLC purchased a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 46,902 shares of the company's stock, valued at approximately $837,000. Nuveen Asset Management LLC owned about 0.14% of Grail as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of GRAL. Lindbrook Capital LLC acquired a new stake in Grail during the fourth quarter valued at approximately $28,000. State of Tennessee Department of Treasury bought a new stake in shares of Grail in the 4th quarter valued at approximately $28,000. Sterling Capital Management LLC bought a new stake in shares of Grail in the 4th quarter valued at approximately $29,000. Wellington Shields Capital Management LLC acquired a new stake in shares of Grail during the 4th quarter valued at approximately $33,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Grail during the fourth quarter worth $41,000.

Insider Activity

In related news, CEO Robert P. Ragusa sold 94,035 shares of Grail stock in a transaction dated Friday, May 2nd. The shares were sold at an average price of $33.93, for a total value of $3,190,607.55. Following the sale, the chief executive officer now directly owns 734,627 shares in the company, valued at $24,925,894.11. This trade represents a 11.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Aaron Freidin sold 41,150 shares of the company's stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $1,396,219.50. Following the completion of the transaction, the chief financial officer now owns 294,020 shares of the company's stock, valued at approximately $9,976,098.60. This trade represents a 12.28% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 183,398 shares of company stock valued at $6,222,694. 1.85% of the stock is currently owned by company insiders.

Grail Stock Down 2.9%

Shares of NASDAQ:GRAL traded down $1.13 during trading on Friday, hitting $38.36. 2,102,177 shares of the company traded hands, compared to its average volume of 1,263,474. The business's fifty day moving average is $32.98 and its 200-day moving average is $28.97. The stock has a market capitalization of $1.38 billion and a price-to-earnings ratio of -0.63. Grail, Inc. has a one year low of $12.33 and a one year high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($4.03) by $0.93. The company had revenue of $31.84 million for the quarter, compared to analyst estimates of $35.80 million. On average, analysts forecast that Grail, Inc. will post -15.15 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have weighed in on GRAL. Morgan Stanley boosted their target price on shares of Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 18th. Canaccord Genuity Group lifted their price target on shares of Grail from $32.00 to $43.00 and gave the company a "buy" rating in a report on Wednesday, May 14th.

Grail Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.